Rocket Lab Corp shares moved lower in pre-market action, dipping about 1.1% as the stock continued a multi-session pullback that began after market participants took a closer look at the financial implications of the company’s recently announced $8 billion merger with Iridium Communications. The agreement was formally entered into on June 28, 2026.
Initial investor enthusiasm centered on the possibility of Rocket Lab evolving into a vertically integrated player across space launch and satellite connectivity. That strategic narrative helped lift the stock, but more detailed scrutiny has led to a reassessment of the near-term costs and balance-sheet consequences associated with the transaction.
On the analyst front, Morgan Stanley has chosen to underscore a constructive stance, maintaining an Overweight rating and a $105 price target on Rocket Lab. The firm also expanded its bull-case valuation, increasing that scenario price target to $293 from $185, citing the potential connectivity upside and an enlarged total addressable market should the Iridium deal progress as envisioned.
Even with Morgan Stanley’s supportive view, the stock had already relinquished roughly 16.7% from its post-announcement highs over the prior week. That retreat suggests investors are pricing in execution and leverage risks that more optimistic scenarios do not fully address.
The wider market backdrop has offered little shelter. The Nasdaq Composite was down roughly 1.2% and the S&P 500 off about 0.5%, with selling pressure attributed to valuation concerns around top artificial-intelligence-related names and geopolitical risks that have hit high-multiple, growth-dependent stocks particularly hard. Rocket Lab sits within this cohort of growth-exposed companies.
It is worth noting that Rocket Lab’s operating momentum remains strong on reported metrics. The company recorded a Q1 2026 revenue figure of $200.3 million and reports a backlog in excess of $2.2 billion. Despite those indicators of demand and scale, the market appears sensitive to the financing and integration dynamics of a large-scale acquisition.
Viewed together, recent trading reflects a common post-deal recalibration: an acquisition that initially amplified the company’s strategic prospects is now being analyzed more carefully for its short-term financial impacts, even while the long-term strategic rationale has not been dismissed by Wall Street.
Context for investors
- Deal size relative to Rocket Lab’s current financial profile is the focal point of investor concern.
- Analysts retain constructive long-term views but acknowledge higher-variance outcomes tied to execution and leverage.
- Macro-driven risk-off flows for growth and high-multiple technology names are amplifying downside pressure.